Ronald M. Kurtz M.D.
CIK: 0001295469
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RxSight, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
161.7K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock Option (right to buy)
215K shares- - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
254.8K shares- - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
173.9K shares- - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
96.1K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock option (right to buy)
338.8K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock Option (right to buy)
200K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock Option (right to buy)
149K shares- - Sep 2, 2026RXST
RxSight, Inc.
Sale(S)Direct5.1K shares at avg. $6.96$35K - Aug 31, 2026RXST
RxSight, Inc.
Exercise(M)Direct13.4K shares- - Feb 27, 2026RXST
RxSight, Inc.
Award(A)DirectRestricted Stock Unit
80.5K shares- - Feb 27, 2025RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
215K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 161,654 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock Option (right to buy) | 215,000 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 254,751 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 173,913 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 96,129 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock option (right to buy) | 338,819 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock Option (right to buy) | 200,000 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock Option (right to buy) | 149,000 | - | - | Direct |
| Sep 2, 2026 | RXST RxSight, Inc. | Sale(S) | 5,100 | $6.96 | $35,496 | Direct |
| Aug 31, 2026 | RXST RxSight, Inc. | Exercise(M) | 13,425 | - | $0 | Direct |
| Feb 27, 2026 | RXST RxSight, Inc. | Award(A) Restricted Stock Unit | 80,545 | - | - | Direct |
| Feb 27, 2025 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 215,000 | - | - | Direct |
1-12 of 12 transactions
About Kurtz Ronald M MD
Kurtz Ronald M MD (SEC CIK 0001295469) files insider reports with the SEC as Chief Medical Officer of RxSight, Inc. (RXST).
Signal8 holds 4 ownership filings by Kurtz Ronald M MD, all Form 4s, filed between Feb 27, 2025 and Sep 9, 2026. Those filings report 12 transactions, from Feb 27, 2025 to Sep 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kurtz Ronald M MD's filings is in ALISO VIEJO, CA.
Recent filings by Kurtz Ronald M MD
- Sep 5, 2026: Grant or award of RXST derivative securities (Form 4, code A).
- Sep 5, 2026: Disposition to issuer transaction of RXST derivative securities (Form 4, code D).
- Sep 5, 2026: Grants or awards of RXST derivative securities (3 lines, Form 4, code A).
- Sep 5, 2026: Disposition to issuer transactions of RXST derivative securities (3 lines, Form 4, code D).
- Sep 2, 2026: Open-market sale of RXST shares (Form 4, code S).
Other insiders filing for RxSight, Inc. (RXST)
- Weinberg Eric
- Wilterding Mark, Chief Financial Officer
- Goldshleger Ilya, Chief Operating Officer
- Mottiwala Aziz, President and CEO
- Warner Robert Keith, Director
- PALMISANO ROBERT J, Director